AxoGen and Blueprint Medicines Help Opaleye Return 91% Over the Last Year
James A. Silverman founded Opaleye Management back in 1996 and it was formerly known as Risk/Reward Capital.
Fund Name: | Opaleye Management |
Manager | James A. Silverman |
Portfolio Value | $376,066,250 |
Change This QTR | +1.22% |
No. | Security | Ticker | Shares | Value | Activity | % Port | History |
---|---|---|---|---|---|---|---|
1. | Harrow Health Inc | 3,820,000 | $42,784,000 | +1% | 11.37% | ||
2. | TGTX | 2,215,000 | $37,832,200 | +18% | 10.05% | ||
3. | Acelyrin Inc | 4,146,138 | $30,930,189 | 8.22% | |||
4. | RYTM | 610,000 | $28,041,700 | -7% | 7.45% | ||
5. | OCUL | 6,070,000 | $27,072,200 | -7% | 7.19% |
Symbol | Company | Filed By | Filing Date | Filing |
---|---|---|---|---|
2024-04-09 | ||||
2024-04-08 | ||||
2024-02-14 | ||||
2024-02-14 | ||||
2024-02-09 |